| Metric | Q4 2020 | Q3 2020 | Q4 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $841M | — | — | — | — |
| Op. Income | $171M | — | — | — | — |
| Gross Margin | 58.5% | — | — | — | — |
| Net Margin | 3.2% | — | — | — | — |
| EPS (Diluted) | $0.10 | — | — | — | — |
| Free Cash Flow | $265M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $841M |
| Cost of Revenue | $349M |
| GROSS PROFIT | $492M |
| R&D Expenses | $103M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $218M |
| Other Expenses | $0 |
| Operating Expenses | $321M |
| Cost & Expenses | $670M |
| OPERATING INCOME | $171M |
| Interest Income | $2M |
| Interest Expense | $40M |
| Other Income/Expenses | -$111M |
| INCOME BEFORE TAX | $59M |
| Income Tax Expense | $33M |
| Net Income from Continuing Ops | $27M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $27M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $27M |
| D&A | $145M |
| EBIT | $97M |
| EBITDA | $242M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $841M |
| Cost of Revenue | $349M |
| GROSS PROFIT | $492M |
| R&D Expenses | $103M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $218M |
| Other Expenses | $0 |
| Operating Expenses | $321M |
| Cost & Expenses | $670M |
| OPERATING INCOME | $171M |
| Interest Income | $2M |
| Interest Expense | $40M |
| Other Income/Expenses | -$111M |
| INCOME BEFORE TAX | $59M |
| Income Tax Expense | $33M |
| Net Income from Continuing Ops | $27M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $27M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $27M |
| D&A | $145M |
| EBIT | $97M |
| EBITDA | $242M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $27M |
| Depreciation & Amortization | $145M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $15M |
| Other Non-Cash Items | $55M |
| Change in Working Capital | $41M |
| OPERATING CASH FLOW | $283M |
| Capital Expenditure | -$18M |
| Acquisitions (Net) | -$14M |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$3M |
| NET CASH FROM INVESTING | -$35M |
| Net Debt Issuance | $8M |
| Common Stock Repurchased | -$128.0K |
| Common Dividends Paid | -$48M |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | -$26M |
| FREE CASH FLOW | $265M |
| Net Change in Cash | $240M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.7B |
| Short-Term Investments | $0 |
| Net Receivables | $557M |
| Inventory | $0 |
| Other Current Assets | $129M |
| TOTAL CURRENT ASSETS | $2.4B |
| PP&E (Net) | $452M |
| Goodwill | $4.7B |
| Intangible Assets | $1.6B |
| Long-Term Investments | $76M |
| Tax Assets | $912M |
| Other Non-Current Assets | $124M |
| TOTAL NON-CURRENT ASSETS | $7.8B |
| TOTAL ASSETS | $10.2B |
| Account Payables | $41M |
| Short-Term Debt | $610M |
| Deferred Revenue | $812M |
| Other Current Liabilities | $4M |
| TOTAL CURRENT LIABILITIES | $1.9B |
| Long-Term Debt | $3.6B |
| Deferred Revenue NC | $94M |
| Deferred Tax Liabilities | $149M |
| Other Non-Current Liabilities | $279M |
| TOTAL NON-CURRENT LIABILITIES | $4.3B |
| TOTAL LIABILITIES | $6.2B |
| Common Stock | $1.9B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $2.2B |
| Treasury Stock | -$24M |
| Accum. Other Comp. Income | $18M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $4.0B |
| Minority Interest | $1M |
| TOTAL EQUITY | $4.0B |
| TOTAL LIABILITIES & EQUITY | $10.2B |
| Total Debt | $4.5B |
| Net Debt | $2.8B |
